Home » CONOR MEDSYSTEMS ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION
CONOR MEDSYSTEMS ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION
Conor Medsystems announced that the underwriters of the company's recent initial public offering of its common stock have exercised in full their over-allotment option to purchase an additional 900,000 shares of the company's common stock at a price of $13 per share, before deducting underwriting discounts and commissions.
ArriveNet (http://press.arrivenet.com/bus/article.php/555354.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct